Preparation, writing and redaction of clinical study reports

BlueReg can support in preparing and writing clinical study reports

Providing the redaction proposal document package for submission to the European Medicines Agency (EMA); anonymizing individual patient data (IPD) and redacting commercially confidential information (CCI) to comply with EMA policy 0070 on the publication of clinical data for medicinal products for human use.

 

 

Our experts

Our team can also support you through the entire application process from development, to registration and post-approval management

Associated services

BlueReg can support you with a highly experienced team of professionals in preparing and writing of your clinical study reports, supporting the redaction proposal and document package for submission to the EMA to comply with EMA policy 0070.

Associated services

BlueReg can support you with a highly experienced team of professionals in preparing and writing of your clinical study reports, supporting the redaction proposal and document package for submission to the EMA to comply with EMA policy 0070.

Associated services

BlueReg can support you with a highly experienced team of professionals in preparing and writing of your clinical study reports, supporting the redaction proposal and document package for submission to the EMA to comply with EMA policy 0070.

Associated News